Structure-based design of potent CDK4 selective inhibitor.

被引：0

作者：

Honma, T ^{[1
]}

Hayashi, K ^{[1
]}

Kawanishi, N ^{[1
]}

Yoshizumi, T ^{[1
]}

Hashimoto, N ^{[1
]}

Sugimoto, T ^{[1
]}

Nakamura, K ^{[1
]}

Takaki, T ^{[1
]}

Machida, T ^{[1
]}

Fukasawa, K ^{[1
]}

Hirai, H ^{[1
]}

Iwama, T ^{[1
]}

Ikeura, C ^{[1
]}

Ikuta, M ^{[1
]}

Kamata, K ^{[1
]}

Suzuki-Takahashi, I ^{[1
]}

Hayama, T ^{[1
]}

机构：

[1] Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

136-MEDI

引用

页码：U24 / U24

页数：1

共 50 条

[31] Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors
Jespers, Willem
Oliveira, Ana
Prieto-Diaz, Ruben
Majellaro, Maria
Aqvist, Johan
Sotelo, Eddy
Gutierrez-de-Teran, Hugo
MOLECULES, 2017, 22 (11):
[32] Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor.
Dai, Kang
Keegan, Kathleen
Li, Zhihong
Ji, Ma
Li, Gong
Eksterowicz, John
Suzanne, Coberly
Hollenback, David
Weidner, Margret
Huard, Justin
Liang, Lingming
Alba, Grace
Orf, Jessica
Lo, Mei-Chu
Zhao, Sharon
Ngo, Rachel
Chen, Ada
Liu, Lily
Carlson, Timothy
Mcgee, Lawrence R.
Medina, Julio
Kamb, Alexander
Vlickramasinghe, Dineli
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
[33] Structure-based inhibitor design
Craig, SP
Eakin, AE
VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 58, 2000, 58 : 149 - +
[34] Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target Engagement
Buijnsters, Peter
De Angelis, Meri
Langlois, Xavier
Rombouts, Frederik J. R.
Sanderson, Wendy
Tresadern, Gary
Ritchie, Alison
Trabanco, Andres A.
VanHoof, Greet
Van Roosbroeck, Yves
Andres, Jose-Ignacio
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (09): : 1049 - 1053
[35] Metamorphosis of paroxetine into a highly potent and selective GRK2 inhibitor via structure-based drug design
Waldschmidt, Helen
Homan, Kristoff
Cruz-Rodriguez, Osvaldo
Cato, Marilyn
Bouley, Renee
Wilson, Michael
Cannavo, Alessandro
Song, Jianliang
Cheung, Joseph
Kirchhoff, Paul
Koch, Walter
Tesmer, John
Larsen, Scott
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[36] Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent
Liang, Guyan
Aldous, Suzanne
Merriman, Gregory
Levell, Julian
Pribish, James
Cairns, Jennifer
Chen, Xin
Maignan, Sebastien
Mathieu, Magali
Tsay, Joseph
Sides, Keith
Rebello, Sam
Whitely, Brian
Morize, Isabelle
Pauls, Henry W.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1049 - 1054
[37] Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine
Du, Guangyan
Rao, Suman
Gurbani, Deepak
Henning, Nathaniel J.
Jiang, Jie
Che, Jianwei
Yang, Annan
Ficarro, Scott B.
Marto, Jarrod A.
Aguirre, Andrew J.
Sorger, Peter K.
Westover, Kenneth D.
Zhang, Tinghu
Gray, Nathanael S.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (04) : 1624 - 1641
[38] Cell death induction in resting lymphocytes by pan-Cdk inhibitor, but not by Cdk4/6 selective inhibitor
Kobayashi, Makiko
Takahashi-Suzuki, Ikuko
Shimomura, Toshiyasu
Iwasawa, Yoshikazu
Hirai, Hiroshi
INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 921 - 931
[39] Cell death induction in resting lymphocytes by pan-Cdk inhibitor, but not by Cdk4/6 selective inhibitor
Makiko Kobayashi
Ikuko Takahashi-Suzuki
Toshiyasu Shimomura
Yoshikazu Iwasawa
Hiroshi Hirai
Investigational New Drugs, 2011, 29 : 921 - 931
[40] Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors
Bhide, Rajeev S.
Keon, Alec
Weigelt, Carolyn
Sack, John S.
Schmidt, Robert J.
Lin, Shuqun
Xiao, Hai-Yun
Spergel, Steven H.
Kempson, James
Pitts, William J.
Carman, Julie
Poss, Michael A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (21) : 4908 - 4913

← 1 2 3 4 5 →